Bivalirudin monitored with the ecarin clotting time for anticoagulation during cardiopulmonary bypass

Andreas Koster, Derek Chew, Marcus Gründel, Matthias Bauer, Herman Kuppe, Bruce D. Spiess

Research output: Contribution to journalArticle

70 Citations (Scopus)


Bivalirudin, a new short-acting direct thrombin inhibitor, provides an elimination mechanism independent of specific organ function. We successfully used this new drug, monitored at the point of care via the ecarin clotting time, for anticoagulation during cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia heparin allergy and impaired renal function.

Original languageEnglish
Pages (from-to)383-386
Number of pages4
JournalAnesthesia and Analgesia
Issue number2
Publication statusPublished - 1 Feb 2003
Externally publishedYes

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this